{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:02:40Z","timestamp":1793660560258,"version":"4.5.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10928-026-10052-9","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:16:23Z","timestamp":1785352583000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Construction of a translational whole-body physiologically based pharmacokinetic model to investigate the biodistribution of lipid nanoparticle-based mRNA therapeutics for intracellular protein targets"],"prefix":"10.1007","volume":"53","author":[{"given":"Kenji","family":"Miyazawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hojjat","family":"Bazzazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"issue":"5","key":"10052_CR1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, Sahly E, Essink HM, Kotloff B, Frey K, Novak S, Diemert R, Spector D, Rouphael SA, Creech N, McGettigan CB, Khetan J, Segall S, Solis N, Brosz J, Fierro A, Schwartz C, Neuzil H, Corey K, Group L, C. S (2021) Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med 384(5):403\u2013416. https:\/\/doi.org\/10.1056\/NEJMoa2035389","journal-title":"N Engl J Med"},{"issue":"27","key":"10052_CR2","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Marc P, Moreira G, Zerbini ED, Bailey C, Swanson R, Roychoudhury KA, Koury S, Li K, Kalina P, Cooper WV, Frenck D, Hammitt RW Jr., Group LL, C. C. T (2020) Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med 383(27):2603\u20132615. https:\/\/doi.org\/10.1056\/NEJMoa2034577","journal-title":"N Engl J Med"},{"issue":"8056","key":"10052_CR3","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/s41586-024-08508-4","volume":"639","author":"Z Sethna","year":"2025","unstructured":"Sethna Z, Guasp P, Reiche C, Milighetti M, Ceglia N, Patterson E, Lihm J, Payne G, Lyudovyk O, Rojas LA, Pang N, Ohmoto A, Amisaki M, Zebboudj A, Odgerel Z, Bruno EM, Zhang SL, Cheng C, Elhanati Y, Balachandran VP (2025) RNA neoantigen vaccines prime long-lived CD8(+) T cells in pancreatic cancer. Nature 639(8056):1042\u20131051. https:\/\/doi.org\/10.1038\/s41586-024-08508-4","journal-title":"Nature"},{"issue":"10427","key":"10052_CR4","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S0140-6736(23)02268-7","volume":"403","author":"JS Weber","year":"2024","unstructured":"Weber JS, Carlino MS, Khattak A, Meniawy T, Ansstas G, Taylor MH, Kim KB, McKean M, Long GV, Sullivan RJ, Faries M, Tran TT, Cowey CL, Pecora A, Shaheen M, Segar J, Medina T, Atkinson V, Gibney GT, Zaks T (2024) Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study. Lancet 403(10427):632\u2013644. https:\/\/doi.org\/10.1016\/S0140-6736(23)02268-7","journal-title":"Lancet"},{"issue":"12","key":"10052_CR5","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1038\/s41591-021-01573-6","volume":"27","author":"A August","year":"2021","unstructured":"August A, Attarwala HZ, Himansu S, Kalidindi S, Lu S, Pajon R, Han S, Lecerf JM, Tomassini JE, Hard M, Ptaszek LM, Crowe JE, Zaks T (2021) A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus. Nat Med 27(12):2224\u20132233. https:\/\/doi.org\/10.1038\/s41591-021-01573-6","journal-title":"Nat Med"},{"issue":"7","key":"10052_CR6","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/nm.4356","volume":"23","author":"CR Stadler","year":"2017","unstructured":"Stadler CR, Bahr-Mahmud H, Celik L, Hebich B, Roth AS, Roth RP, Kariko K, Tureci O, Sahin U (2017) Elimination of large tumors in mice by mRNA-encoded bispecific antibodies. Nat Med 23(7):815\u2013817. https:\/\/doi.org\/10.1038\/nm.4356","journal-title":"Nat Med"},{"issue":"5","key":"10052_CR7","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.tips.2024.03.004","volume":"45","author":"L Short","year":"2024","unstructured":"Short L, Holt RA, Cullis PR, Evgin L (2024) Direct in vivo CAR T cell engineering. Trends Pharmacol Sci 45(5):406\u2013418. https:\/\/doi.org\/10.1016\/j.tips.2024.03.004","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"10052_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47460-9","volume":"15","author":"R Baek","year":"2024","unstructured":"Baek R, Coughlan K, Jiang L, Liang M, Ci L, Singh H, Zhang H, Kaushal N, Rajlic IL, Van L, Dimen R, Cavedon A, Yin L, Rice L, Frassetto A, Guey L, Finn P, Martini PGV (2024) Characterizing the mechanism of action for mRNA therapeutics for the treatment of propionic acidemia, methylmalonic acidemia, and phenylketonuria. Nat Commun 15(1):3804. https:\/\/doi.org\/10.1038\/s41467-024-47460-9","journal-title":"Nat Commun"},{"issue":"8009","key":"10052_CR9","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/s41586-024-07266-7","volume":"628","author":"D Koeberl","year":"2024","unstructured":"Koeberl D, Schulze A, Sondheimer N, Lipshutz GS, Geberhiwot T, Li L, Saini R, Luo J, Sikirica V, Jin L, Liang M, Leuchars M, Grunewald S (2024) Interim analyses of a first-in-human phase 1\/2 mRNA trial for propionic acidaemia. Nature 628(8009):872\u2013877. https:\/\/doi.org\/10.1038\/s41586-024-07266-7","journal-title":"Nature"},{"issue":"7","key":"10052_CR10","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/mt.2010.85","volume":"18","author":"A Akinc","year":"2010","unstructured":"Akinc A, Querbes W, De S, Qin J, Frank-Kamenetsky M, Jayaprakash KN, Jayaraman M, Rajeev KG, Cantley WL, Dorkin JR, Butler JS, Qin L, Racie T, Sprague A, Fava E, Zeigerer A, Hope MJ, Zerial M, Sah DW, Maier MA (2010) Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. Mol Ther 18(7):1357\u20131364. https:\/\/doi.org\/10.1038\/mt.2010.85","journal-title":"Mol Ther"},{"issue":"1","key":"10052_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bbrc.2004.12.137","volume":"328","author":"X Yan","year":"2005","unstructured":"Yan X, Kuipers F, Havekes LM, Havinga R, Dontje B, Poelstra K, Scherphof GL, Kamps JA (2005) The role of apolipoprotein E in the elimination of liposomes from blood by hepatocytes in the mouse. Biochem Biophys Res Commun 328(1):57\u201362. https:\/\/doi.org\/10.1016\/j.bbrc.2004.12.137","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10052_CR12","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.tips.2021.03.002","volume":"42","author":"P Patel","year":"2021","unstructured":"Patel P, Ibrahim NM, Cheng K (2021) The Importance of Apparent pKa in the Development of Nanoparticles Encapsulating siRNA and mRNA. Trends Pharmacol Sci 42(6):448\u2013460. https:\/\/doi.org\/10.1016\/j.tips.2021.03.002","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"10052_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109804","volume":"27","author":"T Zhang","year":"2024","unstructured":"Zhang T, Yin H, Li Y, Yang H, Ge K, Zhang J, Yuan Q, Dai X, Naeem A, Weng Y, Huang Y, Liang XJ (2024) Optimized lipid nanoparticles (LNPs) for organ-selective nucleic acids delivery in vivo. iScience 27(6):109804. https:\/\/doi.org\/10.1016\/j.isci.2024.109804","journal-title":"iScience"},{"issue":"12","key":"10052_CR14","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou X, Zaks T, Langer R, Dong Y (2021) Lipid nanoparticles for mRNA delivery. Nat Rev Mater 6(12):1078\u20131094. https:\/\/doi.org\/10.1038\/s41578-021-00358-0","journal-title":"Nat Rev Mater"},{"issue":"1","key":"10052_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10928-011-9232-2","volume":"39","author":"DK Shah","year":"2012","unstructured":"Shah DK, Betts AM (2012) Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human. J Pharmacokinet Pharmacodyn 39(1):67\u201386. https:\/\/doi.org\/10.1007\/s10928-011-9232-2","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"10","key":"10052_CR16","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/psp4.12461","volume":"8","author":"HM Jones","year":"2019","unstructured":"Jones HM, Zhang Z, Jasper P, Luo H, Avery LB, King LE, Neubert H, Barton HA, Betts AM, Webster R (2019) A Physiologically-Based Pharmacokinetic Model for the Prediction of Monoclonal Antibody Pharmacokinetics From In Vitro Data. CPT Pharmacometrics Syst Pharmacol 8(10):738\u2013747. https:\/\/doi.org\/10.1002\/psp4.12461","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"1","key":"10052_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/cpt.1013","volume":"104","author":"M Shebley","year":"2018","unstructured":"Shebley M, Sandhu P, Emami Riedmaier A, Jamei M, Narayanan R, Patel A, Peters SA, Reddy VP, Zheng M, de Zwart L, Beneton M, Bouzom F, Chen J, Chen Y, Cleary Y, Collins C, Dickinson GL, Djebli N, Einolf HJ, Rowland M (2018) Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective. Clin Pharmacol Ther 104(1):88\u2013110. https:\/\/doi.org\/10.1002\/cpt.1013","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10052_CR18","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/psp4.12301","volume":"7","author":"JF Apgar","year":"2018","unstructured":"Apgar JF, Tang JP, Singh P, Balasubramanian N, Burke J, Hodges MR, Lasaro MA, Lin L, Millard BL, Moore K, Jun LS, Sobolov S, Wilkins AK, Gao X (2018) Quantitative Systems Pharmacology Model of hUGT1A1-modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler-Najjar Syndrome Type 1. CPT Pharmacometrics Syst Pharmacol 7(6):404\u2013412. https:\/\/doi.org\/10.1002\/psp4.12301","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10052_CR19","doi-asserted-by":"publisher","unstructured":"Di J, Du Z, Wu K, Jin S, Wang X, Li T, Xu Y (2022) Biodistribution and non-linear gene expression of mRNA LNPs affected by delivery route and particle size.\u00a0Pharm Res\u00a039(1):105\u2013114. https:\/\/doi.org\/10.1007\/s11095-022-03166-5","DOI":"10.1007\/s11095-022-03166-5"},{"key":"10052_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fnano.2024.1330406","author":"K Miyazawa","year":"2024","unstructured":"Miyazawa K, Liu Y, Bazzazi H (2024) Development of a minimal PBPK-QSP modeling platform for LNP-mRNA based therapeutics to study tissue disposition and protein expression dynamics. Front Nanotechnol. https:\/\/doi.org\/10.3389\/fnano.2024.1330406","journal-title":"Front Nanotechnol"},{"issue":"3","key":"10052_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2025.102606","volume":"36","author":"G Fiandaca","year":"2025","unstructured":"Fiandaca G, Campanile E, Leonardelli L, Pettina E, Giampiccolo S, Carstens EJ, Dasti L, Zangani N, Marchetti L (2025) A multiscale physiologically based pharmacokinetic model to support mRNA-encoded BiTE therapy in cancer treatment. Mol Ther Nucleic Acids 36(3):102606. https:\/\/doi.org\/10.1016\/j.omtn.2025.102606","journal-title":"Mol Ther Nucleic Acids"},{"issue":"7","key":"10052_CR22","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1124\/dmd.122.000980","volume":"51","author":"L Ci","year":"2023","unstructured":"Ci L, Hard M, Zhang H, Gandham S, Hua S, Wickwire J, Wehrman T, Slauter R, Auerbach A, Kenney M, Mercer G, Hendrick T, Almarsson O, Cheung E, Burdette D (2023) Biodistribution of Lipid 5, mRNA, and Its Translated Protein Following Intravenous Administration of mRNA-Encapsulated Lipid Nanoparticles in Rats. Drug Metab Dispos 51(7):813\u2013823. https:\/\/doi.org\/10.1124\/dmd.122.000980","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"10052_CR23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s12195-019-00573-4","volume":"12","author":"CD Sago","year":"2019","unstructured":"Sago CD, Krupczak BR, Lokugamage MP, Gan Z, Dahlman JE (2019) Cell Subtypes Within the Liver Microenvironment Differentially Interact with Lipid Nanoparticles. Cell Mol Bioeng 12(5):389\u2013397. https:\/\/doi.org\/10.1007\/s12195-019-00573-4","journal-title":"Cell Mol Bioeng"},{"issue":"50","key":"10052_CR24","doi-asserted-by":"publisher","first-page":"e2310491120","DOI":"10.1073\/pnas.2310491120","volume":"120","author":"J Philipp","year":"2023","unstructured":"Philipp J, Dabkowska A, Reiser A, Frank K, Krzyszton R, Brummer C, Nickel B, Blanchet CE, Sudarsan A, Ibrahim M, Johansson S, Skantze P, Skantze U, Ostman S, Johansson M, Henderson N, Elvevold K, Smedsrod B, Schwierz N, Radler JO (2023) pH-dependent structural transitions in cationic ionizable lipid mesophases are critical for lipid nanoparticle function. Proc Natl Acad Sci U S A 120(50):e2310491120. https:\/\/doi.org\/10.1073\/pnas.2310491120","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10052_CR25","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jtbi.2008.04.011","volume":"254","author":"S Marino","year":"2008","unstructured":"Marino S, Hogue IB, Ray CJ, Kirschner DE (2008) A methodology for performing global uncertainty and sensitivity analysis in systems biology. J Theor Biol 254(1):178\u2013196. https:\/\/doi.org\/10.1016\/j.jtbi.2008.04.011","journal-title":"J Theor Biol"},{"key":"10052_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11040179","author":"M Aborig","year":"2019","unstructured":"Aborig M, Malik PRV, Nambiar S, Chelle P, Darko J, Mutsaers A, Edginton AN, Fleck A, Osei E, Wettig S (2019) Biodistribution and physiologically-based pharmacokinetic modeling of gold nanoparticles in mice with interspecies extrapolation. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics11040179","journal-title":"Pharmaceutics"},{"issue":"2","key":"10052_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2024.102175","volume":"35","author":"H Parhiz","year":"2024","unstructured":"Parhiz H, Shuvaev VV, Li Q, Papp TE, Akyianu AA, Shi R, Yadegari A, Shahnawaz H, Semple SC, Mui BL, Weissman D, Muzykantov VR, Glassman PM (2024) Physiologically based modeling of LNP-mediated delivery of mRNA in the vascular system. Mol Ther Nucleic Acids 35(2):102175. https:\/\/doi.org\/10.1016\/j.omtn.2024.102175","journal-title":"Mol Ther Nucleic Acids"},{"key":"10052_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/nano10071267","author":"W Utembe","year":"2020","unstructured":"Utembe W, Clewell H, Sanabria N, Doganis P, Gulumian M (2020) Current approaches and techniques in physiologically based pharmacokinetic (PBPK) modelling of nanomaterials. Nanomaterials Basel. https:\/\/doi.org\/10.3390\/nano10071267","journal-title":"Nanomaterials Basel"},{"issue":"5","key":"10052_CR29","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1194\/jlr.D600001-JLR200","volume":"47","author":"T Yamamoto","year":"2006","unstructured":"Yamamoto T, Lamoureux J, Ryan RO (2006) Characterization of low density lipoprotein receptor ligand interactions by fluorescence resonance energy transfer. J Lipid Res 47(5):1091\u20131096. https:\/\/doi.org\/10.1194\/jlr.D600001-JLR200","journal-title":"J Lipid Res"},{"key":"10052_CR30","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jconrel.2020.03.006","volume":"322","author":"Y Sato","year":"2020","unstructured":"Sato Y, Kinami Y, Hashiba K, Harashima H (2020) Different kinetics for the hepatic uptake of lipid nanoparticles between the apolipoprotein E\/low density lipoprotein receptor and the N-acetyl-d-galactosamine\/asialoglycoprotein receptor pathway. J Control Release 322:217\u2013226. https:\/\/doi.org\/10.1016\/j.jconrel.2020.03.006","journal-title":"J Control Release"},{"issue":"11","key":"10052_CR31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2307800120","volume":"121","author":"S Chatterjee","year":"2024","unstructured":"Chatterjee S, Kon E, Sharma P, Peer D (2024) Endosomal escape: a bottleneck for LNP-mediated therapeutics. Proc Natl Acad Sci U S A 121(11):e2307800120. https:\/\/doi.org\/10.1073\/pnas.2307800120","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10052_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60959-z","volume":"16","author":"JM Johansson","year":"2025","unstructured":"Johansson JM, Du Rietz H, Hedlund H, Eriksson HC, Oude Blenke E, Pote A, Harun S, Nordenfelt P, Lindfors L, Wittrup A (2025) Cellular and biophysical barriers to lipid nanoparticle mediated delivery of RNA to the cytosol. Nat Commun 16(1):5354. https:\/\/doi.org\/10.1038\/s41467-025-60959-z","journal-title":"Nat Commun"},{"key":"10052_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113879","volume":"384","author":"JB Simonsen","year":"2025","unstructured":"Simonsen JB, Larsson P (2025) A perspective on the apparent pKa of ionizable lipids in mRNA-LNPs. J Control Release 384:113879. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113879","journal-title":"J Control Release"},{"issue":"1","key":"10052_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14527-2","volume":"11","author":"S Patel","year":"2020","unstructured":"Patel S, Ashwanikumar N, Robinson E, Xia Y, Mihai C, Griffith JP 3rd, Hou S, Esposito AA, Ketova T, Welsher K, Joyal JL, Almarsson O, Sahay G (2020) Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA. Nat Commun 11(1):983. https:\/\/doi.org\/10.1038\/s41467-020-14527-2","journal-title":"Nat Commun"},{"issue":"7","key":"10052_CR35","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/s41587-019-0164-5","volume":"37","author":"PJ Sample","year":"2019","unstructured":"Sample PJ, Wang B, Reid DW, Presnyak V, McFadyen IJ, Morris DR, Seelig G (2019) Human 5\u2019 UTR design and variant effect prediction from a massively parallel translation assay. Nat Biotechnol 37(7):803\u2013809. https:\/\/doi.org\/10.1038\/s41587-019-0164-5","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10052_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50568-7","volume":"15","author":"K Jiang","year":"2024","unstructured":"Jiang K, Tian K, Yu Y, Wu E, Yang M, Pan F, Qian J, Zhan C (2024) Kupffer cells determine intrahepatic traffic of PEGylated liposomal doxorubicin. Nat Commun 15(1):6136. https:\/\/doi.org\/10.1038\/s41467-024-50568-7","journal-title":"Nat Commun"},{"key":"10052_CR37","doi-asserted-by":"publisher","first-page":"114238","DOI":"10.1016\/j.addr.2022.114238","volume":"185","author":"W Ngo","year":"2022","unstructured":"Ngo W, Ahmed S, Blackadar C, Bussin B, Ji Q, Mladjenovic SM, Sepahi Z, Chan WCW (2022) Why nanoparticles prefer liver macrophage cell uptake in vivo. Adv Drug Deliv Rev 185:114238. https:\/\/doi.org\/10.1016\/j.addr.2022.114238","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10052_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/s1525-0016(02)00017-5","volume":"7","author":"G Schiedner","year":"2003","unstructured":"Schiedner G, Hertel S, Johnston M, Dries V, van Rooijen N, Kochanek S (2003) Selective depletion or blockade of Kupffer cells leads to enhanced and prolonged hepatic transgene expression using high-capacity adenoviral vectors. Mol Ther 7(1):35\u201343. https:\/\/doi.org\/10.1016\/s1525-0016(02)00017-5","journal-title":"Mol Ther"},{"issue":"42","key":"10052_CR39","doi-asserted-by":"publisher","first-page":"7419","DOI":"10.1039\/c4tb01316f","volume":"2","author":"G Caracciolo","year":"2014","unstructured":"Caracciolo G, Pozzi D, Capriotti AL, Cavaliere C, Piovesana S, La Barbera G, Amici A, Lagana A (2014) The liposome-protein corona in mice and humans and its implications for in vivo delivery. J Mater Chem B 2(42):7419\u20137428. https:\/\/doi.org\/10.1039\/c4tb01316f","journal-title":"J Mater Chem B"},{"issue":"1","key":"10052_CR40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s11658-024-00655-w","volume":"29","author":"I Czyzynska-Cichon","year":"2024","unstructured":"Czyzynska-Cichon I, Kotlinowski J, Blacharczyk O, Giergiel M, Szymanowski K, Metwally S, Wojnar-Lason K, Dobosz E, Koziel J, Lekka M, Chlopicki S, Zapotoczny B (2024) Early and late phases of liver sinusoidal endothelial cell (LSEC) defenestration in mouse model of systemic inflammation. Cell Mol Biol Lett 29(1):139. https:\/\/doi.org\/10.1186\/s11658-024-00655-w","journal-title":"Cell Mol Biol Lett"},{"issue":"8","key":"10052_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107521","volume":"300","author":"K Yamamoto","year":"2024","unstructured":"Yamamoto K, Scilabra SD, Bonelli S, Jensen A, Scavenius C, Enghild JJ, Strickland DK (2024) Novel insights into the multifaceted and tissue-specific roles of the endocytic receptor LRP1. J Biol Chem 300(8):107521. https:\/\/doi.org\/10.1016\/j.jbc.2024.107521","journal-title":"J Biol Chem"},{"issue":"2","key":"10052_CR42","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1093\/nar\/gkaa1103","volume":"49","author":"MV Gerashchenko","year":"2021","unstructured":"Gerashchenko MV, Peterfi Z, Yim SH, Gladyshev VN (2021) Translation elongation rate varies among organs and decreases with age. Nucleic Acids Res 49(2):e9. https:\/\/doi.org\/10.1093\/nar\/gkaa1103","journal-title":"Nucleic Acids Res"},{"key":"10052_CR43","doi-asserted-by":"publisher","unstructured":"Wek RC (2018) Role of eIF2alpha Kinases in translational control and adaptation to cellular stress. Cold Spring Harb Perspect Biol 10(7). https:\/\/doi.org\/10.1101\/cshperspect.a032870","DOI":"10.1101\/cshperspect.a032870"}],"container-title":["Journal of Pharmacokinetics and Pharmacodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-026-10052-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10928-026-10052-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-026-10052-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:21:45Z","timestamp":1792106505000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10928-026-10052-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10052"],"URL":"https:\/\/doi.org\/10.1007\/s10928-026-10052-9","relation":{},"ISSN":["1567-567X","1573-8744"],"issn-type":[{"value":"1567-567X","type":"print"},{"value":"1573-8744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"23 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"48"}}